Identification of an antigenic determinant of collagen treated with hydroxylamine

Identification of an antigenic determinant of collagen treated with hydroxylamine

Play all audios:

Loading...

ABSTRACT THE treatment of collagen with hydroxylamine, which splits ester-like bonds, produces subunits carrying newly formed aspartic acid hydroxamates1,2. Their alcohol counterparts are not yet fully identified. A series of investigations on the immunogenicity and specificity of collagen3,4 showed that collagen treated with hydroxylamine (HC) is an antigen which induces the formation of two types of immune sera: type 1 containing only antibodies against the area of hydroxylamine treatment (HC-antibodies); type 2 containing additionally antibodies against the general collagen structure. HC therefore acts when used for immunization like a conjugated protein. Investigation of haemagglutination inhibition showed that early sera were predominantly of type 2. Hyperimmune sera, however, were mostly of type 1. Inhibition experiments proved that sera with only HC-antibodies (type 1 immune sera) can be inhibited by HC, but are not inhibited by collagen preparations such as parent gelatine. Antisera which possess both antibodies (type 2 immune sera) are inhibited extensively by HC and to a lesser degree by parent gelatine. Additionally, inhibition experiments were carried out with peptides obtained from HC, acid-soluble collagen and insoluble collagen by treatment with trypsin or colla-genase5. Only peptides obtained from HC inhibited HC-antibodies and these peptides when used in sufficient amounts caused a complete inhibition of potent antisera. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 51 print issues and online access $199.00 per year only $3.90 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS A FRUCTOSYLATED PEPTIDE DERIVED FROM A COLLAGEN II T CELL EPITOPE FOR LONG-TERM TREATMENT OF ARTHRITIS (FIA-CIA) IN MICE Article Open access 30 August 2021 SERUM COMPONENTS INFLUENCE ANTIBODY REACTIVITY TO GLYCAN AND DNA ANTIGENS Article Open access 22 August 2023 REGULATORY PROPERTIES OF VITRONECTIN AND ITS GLYCOSYLATION IN COLLAGEN FIBRIL FORMATION AND COLLAGEN-DEGRADING ENZYME CATHEPSIN K ACTIVITY Article Open access 08 June 2021 REFERENCES * Gallop, P. M., Seifter, S., and Meilman, E., _Nature_, 183, 1659 (1959). Article  ADS  CAS  Google Scholar  * Blumenfeld, O. O., and Gallop, P. M., _Biochemistry_, 1, 947 (1962). Article  CAS  Google Scholar  * Steffen, C., Timpl, R., and Wolff, I., _Z. Immunitätsforsch._, 124, 476 (1962). Google Scholar  * Steffen, C., Timpl, R., and Wolff, I., _J. Immunol._, 93, 656 (1964). CAS  PubMed  Google Scholar  * Steffen, C., and Timpl, R., _Z. Immunitätsforsch._, 130, 3 (1966). CAS  Google Scholar  * Springer, G. F., and Williamson, P., _Biochem. J._, 85, 282 (1962). Article  CAS  Google Scholar  * Hörmann, H., _Leder_, 11, 173 (1960). Google Scholar  * Porter, R. R., and Press, E. M., _Ann. Rev. Biochem._, 31, 625 (1962). Article  CAS  Google Scholar  Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Klinisches Laboratorium, Hanuschkrankenhaus, Vienna, Austria C. STEFFEN, R. TIMPL & I. WOLFF Authors * C. STEFFEN View author publications You can also search for this author inPubMed Google Scholar * R. TIMPL View author publications You can also search for this author inPubMed Google Scholar * I. WOLFF View author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE STEFFEN, C., TIMPL, R. & WOLFF, I. Identification of an Antigenic Determinant of Collagen treated with Hydroxylamine. _Nature_ 213, 497–498 (1967). https://doi.org/10.1038/213497a0 Download citation * Issue Date: 04 February 1967 * DOI: https://doi.org/10.1038/213497a0 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative

ABSTRACT THE treatment of collagen with hydroxylamine, which splits ester-like bonds, produces subunits carrying newly formed aspartic acid hydroxamates1,2. Their alcohol counterparts are


not yet fully identified. A series of investigations on the immunogenicity and specificity of collagen3,4 showed that collagen treated with hydroxylamine (HC) is an antigen which induces the


formation of two types of immune sera: type 1 containing only antibodies against the area of hydroxylamine treatment (HC-antibodies); type 2 containing additionally antibodies against the


general collagen structure. HC therefore acts when used for immunization like a conjugated protein. Investigation of haemagglutination inhibition showed that early sera were predominantly of


type 2. Hyperimmune sera, however, were mostly of type 1. Inhibition experiments proved that sera with only HC-antibodies (type 1 immune sera) can be inhibited by HC, but are not inhibited


by collagen preparations such as parent gelatine. Antisera which possess both antibodies (type 2 immune sera) are inhibited extensively by HC and to a lesser degree by parent gelatine.


Additionally, inhibition experiments were carried out with peptides obtained from HC, acid-soluble collagen and insoluble collagen by treatment with trypsin or colla-genase5. Only peptides


obtained from HC inhibited HC-antibodies and these peptides when used in sufficient amounts caused a complete inhibition of potent antisera. Access through your institution Buy or subscribe


This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 51 print issues and online access


$199.00 per year only $3.90 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are


calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS A


FRUCTOSYLATED PEPTIDE DERIVED FROM A COLLAGEN II T CELL EPITOPE FOR LONG-TERM TREATMENT OF ARTHRITIS (FIA-CIA) IN MICE Article Open access 30 August 2021 SERUM COMPONENTS INFLUENCE ANTIBODY


REACTIVITY TO GLYCAN AND DNA ANTIGENS Article Open access 22 August 2023 REGULATORY PROPERTIES OF VITRONECTIN AND ITS GLYCOSYLATION IN COLLAGEN FIBRIL FORMATION AND COLLAGEN-DEGRADING ENZYME


CATHEPSIN K ACTIVITY Article Open access 08 June 2021 REFERENCES * Gallop, P. M., Seifter, S., and Meilman, E., _Nature_, 183, 1659 (1959). Article  ADS  CAS  Google Scholar  * Blumenfeld,


O. O., and Gallop, P. M., _Biochemistry_, 1, 947 (1962). Article  CAS  Google Scholar  * Steffen, C., Timpl, R., and Wolff, I., _Z. Immunitätsforsch._, 124, 476 (1962). Google Scholar  *


Steffen, C., Timpl, R., and Wolff, I., _J. Immunol._, 93, 656 (1964). CAS  PubMed  Google Scholar  * Steffen, C., and Timpl, R., _Z. Immunitätsforsch._, 130, 3 (1966). CAS  Google Scholar  *


Springer, G. F., and Williamson, P., _Biochem. J._, 85, 282 (1962). Article  CAS  Google Scholar  * Hörmann, H., _Leder_, 11, 173 (1960). Google Scholar  * Porter, R. R., and Press, E. M.,


_Ann. Rev. Biochem._, 31, 625 (1962). Article  CAS  Google Scholar  Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Klinisches Laboratorium, Hanuschkrankenhaus, Vienna,


Austria C. STEFFEN, R. TIMPL & I. WOLFF Authors * C. STEFFEN View author publications You can also search for this author inPubMed Google Scholar * R. TIMPL View author publications You


can also search for this author inPubMed Google Scholar * I. WOLFF View author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and


permissions ABOUT THIS ARTICLE CITE THIS ARTICLE STEFFEN, C., TIMPL, R. & WOLFF, I. Identification of an Antigenic Determinant of Collagen treated with Hydroxylamine. _Nature_ 213,


497–498 (1967). https://doi.org/10.1038/213497a0 Download citation * Issue Date: 04 February 1967 * DOI: https://doi.org/10.1038/213497a0 SHARE THIS ARTICLE Anyone you share the following


link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature


SharedIt content-sharing initiative